Stockscreener 앱 받기
17.73
2.58%
-0.47
시장 영업 전:
16.51
-1.22
-6.88%
전일 마감가:
$18.20
열려 있는:
$17.24
하루 거래량:
618.96K
Relative Volume:
1.57
시가총액:
$1.03B
수익:
$1.12B
순이익/손실:
$55.30M
주가수익비율:
18.66
EPS:
0.95
순현금흐름:
$-30.30M
1주 성능:
-3.43%
1개월 성능:
-15.29%
6개월 성능:
+23.38%
1년 성능:
+1.90%
1일 변동 폭
$16.12
$18.12
1주일 범위
$16.12
$18.58
52주 변동 폭
$9.925
$21.48
Embecta Corp Stock (EMBC) Company Profile
명칭
Embecta Corp
전화
(862) 401-0000
주소
1209 ORANGE STREET, WILMINGTON
EMBC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EMBC
Embecta Corp
|
17.73 | 1.03B | 1.12B | 55.30M | -30.30M | 0.95 |
|
ISRG
Intuitive Surgical Inc
|
588.50 | 209.89B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
227.21 | 68.23B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
91.65 | 45.33B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
237.18 | 34.84B | 4.93B | 1.25B | 1.38B | 8.47 |
|
WST
West Pharmaceutical Services Inc
|
330.47 | 23.97B | 2.88B | 499.60M | 321.60M | 6.74 |
Embecta Corp Stock (EMBC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-02 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-27 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2023-10-20 | 개시 | Wolfe Research | Peer Perform |
| 2023-01-06 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2022-09-08 | 개시 | BTIG Research | Neutral |
| 2022-08-01 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-06-21 | 개시 | BofA Securities | Underperform |
모두보기
Embecta Corp 주식(EMBC)의 최신 뉴스
Embecta Corporation Reports Q1 2025 Earnings Amid Strategic Shifts - TipRanks
Embecta earnings beat by $0.21, revenue topped estimates - Investing.com Nigeria
Embecta Corp’s Earnings Call: Growth Amid Challenges - TipRanks
Embecta earnings beat by $0.21, revenue topped estimates By Investing.com - Investing.com South Africa
Embecta Keeps Quarterly Dividend at $0.15 Per Share, Payable March 14 to Stockholders of Record on Feb. 28 - Marketscreener.com
Becton Dickinson Q1 Earnings: Revenue And EPS Beat, Lowers Outlook, Outlines Intent To Separate Biosciences And Diagnostic Solutions Business - Benzinga
Embecta Corp. Announces Quarterly Cash Dividend, Payable March 14, 2025 -February 06, 2025 at 06:00 am EST - Marketscreener.com
Embecta Corp. (EMBC) Tops Q1 Earnings and Revenue Estimates - MSN
Embecta's Fiscal Q1 Adjusted Earnings Rise, Revenue Declines -February 06, 2025 at 08:43 am EST - Marketscreener.com
Embecta stock rises on Street-beating Q1 - Drug Delivery Business News
Embecta Announces Quarterly Cash Dividend -February 06, 2025 at 06:01 am EST - Marketscreener.com
Embecta (NASDAQ:EMBC) Releases FY 2025 Earnings Guidance - MarketBeat
Embecta Posts Mixed Q1 Results: EPS Beats Despite Revenue Pressure, Management Raises Key Metrics Outlook - StockTitan
Embecta Announces Quarterly Cash Dividend - Barchart
(EMBC) EMBECTA CORP. Forecasts Fiscal Year 2025 Adjusted EPS Range $2.70$2.90 - Marketscreener.com
Embecta Corp. Reports First Quarter Fiscal 2025 Financial Results - The Manila Times
embecta Announces Quarterly Cash Dividend - GlobeNewswire
Activist Starboard Value Pushes Becton Dickinson To Divest Life Sciences Unit - Benzinga
Embecta (EMBC) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
(EMBC) Proactive Strategies - Stock Traders Daily
Embecta Sets Earnings Call Date: Q1 2025 Financial Results Coming February 6 - StockTitan
embecta to Report Fiscal First Quarter 2025 Financial Results - The Bakersfield Californian
The Zacks Analyst Blog Doximity, Omnicell, Embecta, Cencora and EDOC - Zacks Investment Research
YieldBoost Embecta From 3.3% To 33.2% Using Options - Nasdaq
Embecta Corp. (NASDAQ:EMBC) Shares Acquired by JPMorgan Chase & Co. - Defense World
Is Embecta a Medical Device Company Worth Adding to Your Portfolio? - Inkl
EMBC: Is Embecta a Medical Device Company Worth Adding to Your Portfolio? - StockNews.com
Contrasting Steakholder Foods (OTCMKTS:MTTCF) & Embecta (NASDAQ:EMBC) - Defense World
Is Embecta Back on Track After a Tough Year? - MD+DI
Analysts say Embecta is ‘heading in the right direction’ following patch pump discontinuation - Mass Device
Analysts say Embecta is 'heading in the right direction' - Drug Delivery Business News
Embecta (NASDAQ:EMBC) Trading Down 4%Here's What Happened - MarketBeat
The mission: To improve the lives of half a billion people worldwide - Fast Company
Barclays PLC Buys 28,523 Shares of Embecta Corp. (NASDAQ:EMBC) - Defense World
Barclays PLC Has $1.38 Million Stake in Embecta Corp. (NASDAQ:EMBC) - MarketBeat
Strength Seen in Embecta Corp. (EMBC): Can Its 6.9% Jump Turn into More Strength? - MSN
The Zacks Analyst Blog Highlights Doximity, BrightSpring Health Services and Embecta - Yahoo Finance
BDX: 3 Healthcare Innovators Advancing Medical Technology - StockNews.com
Principal Financial Group Inc. Sells 12,593 Shares of Embecta Corp. (NASDAQ:EMBC) - Defense World
Embecta Corp. (NASDAQ:EMBC) Stock Position Raised by Barclays PLC - MarketBeat
Geode Capital Management LLC Purchases 45,228 Shares of Embecta Corp. (NASDAQ:EMBC) - MarketBeat
Embecta Corp. (NASDAQ:EMBC) Shares Purchased by Barclays PLC - Defense World
Zacks.com featured highlights include The Gap, Embecta, Blue Bird and ZIM Integrated Shipping Services - Yahoo Finance
Embecta Corp. (NASDAQ:EMBC) Shares Purchased by Jane Street Group LLC - MarketBeat
Embecta Corp. (NASDAQ:EMBC) Shares Sold by State Street Corp - Defense World
Embecta to Participate at the 43rd Annual J.P. Morgan Healthcare Conference - Marketscreener.com
embecta to Participate at the 43rd Annual J.P. Morgan Healthcare Conference - Eagle-Tribune
Embecta To Participate At The 43rd Annual J.P. Morgan Healthcare Conference - Barchart
Embecta to Present at J.P. Morgan Healthcare Conference 2025: Key Updates Expected - StockTitan
Embecta Corp. Announces Quarterly Cash Dividend, Payable December 18, 2024 - Marketscreener.com
Embecta Corp. (NASDAQ:EMBC) Sees Significant Drop in Short Interest - MarketBeat
Embecta Corp (EMBC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
10.10%
0.93%
자본화:
|
볼륨(24시간):